YAP regulates HER3 signaling-driven adaptive resistance to RET inhibitors in RET-aberrant cancer
{{output}}
Purpose: Rearranged during transfection (RET) aberrations represent a targetable oncogene in several tumor types, with RET inhibitors displaying marked efficacy. However, some patients with RET-aberrant cancer are insensitive to ... ...
